Ferumoxytol versus other intravenous iron therapies for anemia a review of the clinical and cost-effectiveness and guidelines - an update
Ferumoxytol (Feraheme) is a colloidal superparamegnetic iron-carbohydrate complex that was specifically designed to reduce immunological reactivity. It can be rapidly administered (IV rate of 30-60 seconds) as a 510 mg dose with the second IV injection administered two to eight days later. The feder...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottawa]
Canadian Agency for Drugs and Technologies in Health
2014, 21 November 2014
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references